PRE [NASD]
Prenetics Global Limited
Index- P/E- EPS (ttm)-2.50 Insider Own37.63% Shs Outstand110.98M Perf Week-0.55%
Market Cap265.53M Forward P/E- EPS next Y-0.28 Insider Trans0.00% Shs Float69.22M Perf Month-42.36%
Income-277.80M PEG- EPS next Q-0.10 Inst Own9.30% Short Float / Ratio0.29% / 4.50 Perf Quarter-53.95%
Sales288.20M P/S0.92 EPS this Y- Inst Trans-1.49% Short Interest0.20M Perf Half Y-64.16%
Book/sh1.87 P/B0.97 EPS next Y88.30% ROA-128.30% Target Price11.55 Perf Year-76.48%
Cash/sh1.16 P/C1.56 EPS next 5Y- ROE278.30% 52W Range1.24 - 8.75 Perf YTD-76.44%
Dividend- P/FCF- EPS past 5Y- ROI-15.50% 52W High-79.32% Beta-
Dividend %- Quick Ratio4.90 Sales past 5Y- Gross Margin44.50% 52W Low45.96% ATR0.23
Employees800 Current Ratio5.00 Sales Q/Q6.70% Oper. Margin-50.30% RSI (14)24.88 Volatility4.96% 12.48%
OptionableNo Debt/Eq0.07 EPS Q/Q81.50% Profit Margin-96.40% Rel Volume0.91 Prev Close1.85
ShortableYes LT Debt/Eq0.01 EarningsNov 10 BMO Payout- Avg Volume45.08K Price1.81
Recom1.00 SMA20-26.16% SMA50-41.64% SMA200-64.12% Volume40,971 Change-2.17%
Nov-30-22 09:15AM
Nov-10-22 08:00AM
Sep-09-22 11:17AM
09:02AM
Aug-12-22 09:34AM
04:45AM Loading…
Aug-08-22 04:45AM
Jul-16-22 08:03AM
Jun-08-22 12:56PM
Jun-06-22 09:55AM
May-23-22 12:00PM
08:46AM
May-19-22 12:15PM
May-18-22 06:30PM
May-17-22 11:00AM
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.